nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—lung cancer	0.284	1	CbGaD
Methylprednisolone—ABCB1—Topotecan—lung cancer	0.0408	0.0864	CbGbCtD
Methylprednisolone—ABCB1—Gefitinib—lung cancer	0.0373	0.079	CbGbCtD
Methylprednisolone—ABCB1—Vinorelbine—lung cancer	0.0287	0.0609	CbGbCtD
Methylprednisolone—CYP3A4—Topotecan—lung cancer	0.0244	0.0518	CbGbCtD
Methylprednisolone—ABCB1—Crizotinib—lung cancer	0.0229	0.0484	CbGbCtD
Methylprednisolone—CYP3A4—Gefitinib—lung cancer	0.0224	0.0473	CbGbCtD
Methylprednisolone—ABCB1—Gemcitabine—lung cancer	0.0224	0.0473	CbGbCtD
Methylprednisolone—ABCB1—Erlotinib—lung cancer	0.0221	0.0467	CbGbCtD
Methylprednisolone—CYP3A4—Teniposide—lung cancer	0.0217	0.0459	CbGbCtD
Methylprednisolone—ABCB1—Paclitaxel—lung cancer	0.0202	0.0428	CbGbCtD
Methylprednisolone—ABCB1—Irinotecan—lung cancer	0.0199	0.0422	CbGbCtD
Methylprednisolone—ABCB1—Vinblastine—lung cancer	0.0177	0.0375	CbGbCtD
Methylprednisolone—CYP3A4—Vinorelbine—lung cancer	0.0172	0.0365	CbGbCtD
Methylprednisolone—ABCB1—Cisplatin—lung cancer	0.0162	0.0344	CbGbCtD
Methylprednisolone—ABCB1—Etoposide—lung cancer	0.016	0.0338	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—lung cancer	0.0146	0.0309	CbGbCtD
Methylprednisolone—CYP3A4—Crizotinib—lung cancer	0.0137	0.029	CbGbCtD
Methylprednisolone—CYP3A4—Erlotinib—lung cancer	0.0132	0.028	CbGbCtD
Methylprednisolone—CYP3A4—Paclitaxel—lung cancer	0.0121	0.0256	CbGbCtD
Methylprednisolone—CYP3A4—Irinotecan—lung cancer	0.0119	0.0253	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—lung cancer	0.0109	0.023	CbGbCtD
Methylprednisolone—CYP3A4—Vinblastine—lung cancer	0.0106	0.0225	CbGbCtD
Methylprednisolone—ABCB1—Methotrexate—lung cancer	0.0105	0.0223	CbGbCtD
Methylprednisolone—CYP3A4—Etoposide—lung cancer	0.00956	0.0202	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—lung cancer	0.00875	0.0185	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—lung cancer	0.00652	0.0138	CbGbCtD
Methylprednisolone—Hydrocortisone—ANXA1—lung cancer	0.000561	0.204	CrCbGaD
Methylprednisolone—Dexamethasone—ANXA1—lung cancer	0.000418	0.152	CrCbGaD
Methylprednisolone—Clobetasol propionate—CYP1A1—lung cancer	0.00024	0.0871	CrCbGaD
Methylprednisolone—Prednisolone—CYP2A6—lung cancer	0.000225	0.0817	CrCbGaD
Methylprednisolone—Hydrocortisone—ABCG2—lung cancer	0.000154	0.0559	CrCbGaD
Methylprednisolone—Dexamethasone—CYP2A6—lung cancer	0.000128	0.0465	CrCbGaD
Methylprednisolone—Triamcinolone—PTGS2—lung cancer	0.000118	0.0428	CrCbGaD
Methylprednisolone—Dexamethasone—ABCG2—lung cancer	0.000115	0.0416	CrCbGaD
Methylprednisolone—Discomfort—Etoposide—lung cancer	0.000105	0.000546	CcSEcCtD
Methylprednisolone—Mental disorder—Docetaxel—lung cancer	0.000105	0.000543	CcSEcCtD
Methylprednisolone—Arthralgia—Paclitaxel—lung cancer	0.000104	0.000542	CcSEcCtD
Methylprednisolone—Myalgia—Paclitaxel—lung cancer	0.000104	0.000542	CcSEcCtD
Methylprednisolone—Hypotension—Cisplatin—lung cancer	0.000104	0.00054	CcSEcCtD
Methylprednisolone—Anxiety—Paclitaxel—lung cancer	0.000104	0.00054	CcSEcCtD
Methylprednisolone—Erythema—Docetaxel—lung cancer	0.000104	0.000539	CcSEcCtD
Methylprednisolone—Malnutrition—Docetaxel—lung cancer	0.000104	0.000539	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000104	0.000538	CcSEcCtD
Methylprednisolone—Nausea—Topotecan—lung cancer	0.000103	0.000536	CcSEcCtD
Methylprednisolone—Discomfort—Paclitaxel—lung cancer	0.000103	0.000535	CcSEcCtD
Methylprednisolone—Fatigue—Gemcitabine—lung cancer	0.000103	0.000535	CcSEcCtD
Methylprednisolone—Confusional state—Etoposide—lung cancer	0.000103	0.000534	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—lung cancer	0.000102	0.000531	CcSEcCtD
Methylprednisolone—Nausea—Erlotinib—lung cancer	0.000102	0.00053	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Etoposide—lung cancer	0.000102	0.00053	CcSEcCtD
Methylprednisolone—Mood swings—Doxorubicin—lung cancer	0.000102	0.000529	CcSEcCtD
Methylprednisolone—Diarrhoea—Vinorelbine—lung cancer	0.000102	0.000528	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000102	0.000527	CcSEcCtD
Methylprednisolone—Infection—Etoposide—lung cancer	0.000101	0.000526	CcSEcCtD
Methylprednisolone—Feeling abnormal—Irinotecan—lung cancer	0.000101	0.000525	CcSEcCtD
Methylprednisolone—Confusional state—Paclitaxel—lung cancer	0.000101	0.000523	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Irinotecan—lung cancer	0.0001	0.000521	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Paclitaxel—lung cancer	0.0001	0.000519	CcSEcCtD
Methylprednisolone—Paraesthesia—Cisplatin—lung cancer	0.0001	0.000519	CcSEcCtD
Methylprednisolone—Tachycardia—Etoposide—lung cancer	9.96e-05	0.000517	CcSEcCtD
Methylprednisolone—Infection—Paclitaxel—lung cancer	9.94e-05	0.000516	CcSEcCtD
Methylprednisolone—Skin disorder—Etoposide—lung cancer	9.92e-05	0.000514	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Etoposide—lung cancer	9.87e-05	0.000512	CcSEcCtD
Methylprednisolone—Feeling abnormal—Gemcitabine—lung cancer	9.85e-05	0.000511	CcSEcCtD
Methylprednisolone—Shock—Paclitaxel—lung cancer	9.85e-05	0.000511	CcSEcCtD
Methylprednisolone—Dizziness—Vinorelbine—lung cancer	9.84e-05	0.00051	CcSEcCtD
Methylprednisolone—Nervous system disorder—Paclitaxel—lung cancer	9.82e-05	0.000509	CcSEcCtD
Methylprednisolone—Tachycardia—Paclitaxel—lung cancer	9.77e-05	0.000507	CcSEcCtD
Methylprednisolone—Breast disorder—Doxorubicin—lung cancer	9.74e-05	0.000505	CcSEcCtD
Methylprednisolone—Skin disorder—Paclitaxel—lung cancer	9.72e-05	0.000504	CcSEcCtD
Methylprednisolone—Abdominal pain—Irinotecan—lung cancer	9.7e-05	0.000503	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Paclitaxel—lung cancer	9.68e-05	0.000502	CcSEcCtD
Methylprednisolone—Betamethasone—PTGS2—lung cancer	9.65e-05	0.035	CrCbGaD
Methylprednisolone—Infestation—Methotrexate—lung cancer	9.59e-05	0.000497	CcSEcCtD
Methylprednisolone—Infestation NOS—Methotrexate—lung cancer	9.59e-05	0.000497	CcSEcCtD
Methylprednisolone—Hypotension—Etoposide—lung cancer	9.54e-05	0.000495	CcSEcCtD
Methylprednisolone—Prednisone—ALB—lung cancer	9.52e-05	0.0346	CrCbGaD
Methylprednisolone—Muscular weakness—Doxorubicin—lung cancer	9.5e-05	0.000493	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—lung cancer	9.5e-05	0.000493	CcSEcCtD
Methylprednisolone—Vomiting—Vinorelbine—lung cancer	9.46e-05	0.000491	CcSEcCtD
Methylprednisolone—Rash—Vinorelbine—lung cancer	9.38e-05	0.000487	CcSEcCtD
Methylprednisolone—Dermatitis—Vinorelbine—lung cancer	9.37e-05	0.000486	CcSEcCtD
Methylprednisolone—Abdominal distension—Doxorubicin—lung cancer	9.37e-05	0.000486	CcSEcCtD
Methylprednisolone—Hypotension—Paclitaxel—lung cancer	9.35e-05	0.000485	CcSEcCtD
Methylprednisolone—Headache—Vinorelbine—lung cancer	9.32e-05	0.000484	CcSEcCtD
Methylprednisolone—Syncope—Docetaxel—lung cancer	9.32e-05	0.000484	CcSEcCtD
Methylprednisolone—Sweating—Methotrexate—lung cancer	9.19e-05	0.000477	CcSEcCtD
Methylprednisolone—Feeling abnormal—Cisplatin—lung cancer	9.18e-05	0.000476	CcSEcCtD
Methylprednisolone—Paraesthesia—Etoposide—lung cancer	9.17e-05	0.000475	CcSEcCtD
Methylprednisolone—Loss of consciousness—Docetaxel—lung cancer	9.14e-05	0.000474	CcSEcCtD
Methylprednisolone—Pancreatitis—Doxorubicin—lung cancer	9.13e-05	0.000474	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.12e-05	0.000473	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP2E1—lung cancer	9.11e-05	0.033	CrCbGaD
Methylprednisolone—Prednisone—ABCB1—lung cancer	9.09e-05	0.033	CrCbGaD
Methylprednisolone—Insomnia—Paclitaxel—lung cancer	9.05e-05	0.00047	CcSEcCtD
Methylprednisolone—Hypersensitivity—Irinotecan—lung cancer	9.04e-05	0.000469	CcSEcCtD
Methylprednisolone—Convulsion—Docetaxel—lung cancer	9.01e-05	0.000467	CcSEcCtD
Methylprednisolone—Paraesthesia—Paclitaxel—lung cancer	8.99e-05	0.000466	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP1A1—lung cancer	8.98e-05	0.0326	CrCbGaD
Methylprednisolone—Hypertension—Docetaxel—lung cancer	8.98e-05	0.000466	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	8.86e-05	0.00183	CbGpPWpGaD
Methylprednisolone—Arthralgia—Docetaxel—lung cancer	8.85e-05	0.000459	CcSEcCtD
Methylprednisolone—Myalgia—Docetaxel—lung cancer	8.85e-05	0.000459	CcSEcCtD
Methylprednisolone—Nausea—Vinorelbine—lung cancer	8.84e-05	0.000458	CcSEcCtD
Methylprednisolone—Dyspepsia—Paclitaxel—lung cancer	8.81e-05	0.000457	CcSEcCtD
Methylprednisolone—Asthenia—Irinotecan—lung cancer	8.81e-05	0.000457	CcSEcCtD
Methylprednisolone—Fatigue—Etoposide—lung cancer	8.8e-05	0.000457	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.79e-05	0.000456	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—FASLG—lung cancer	8.73e-05	0.0018	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	8.71e-05	0.0018	CbGpPWpGaD
Methylprednisolone—Haemoglobin—Methotrexate—lung cancer	8.65e-05	0.000449	CcSEcCtD
Methylprednisolone—Fatigue—Paclitaxel—lung cancer	8.63e-05	0.000448	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	8.62e-05	0.00178	CbGpPWpGaD
Methylprednisolone—Haemorrhage—Methotrexate—lung cancer	8.61e-05	0.000446	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	8.58e-05	0.00177	CbGpPWpGaD
Methylprednisolone—Asthenia—Gemcitabine—lung cancer	8.58e-05	0.000445	CcSEcCtD
Methylprednisolone—Confusional state—Docetaxel—lung cancer	8.56e-05	0.000444	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—EIF2B4—lung cancer	8.55e-05	0.00177	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	8.55e-05	0.00176	CbGpPWpGaD
Methylprednisolone—Anaphylactic shock—Docetaxel—lung cancer	8.48e-05	0.00044	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—lung cancer	8.47e-05	0.00044	CcSEcCtD
Methylprednisolone—Pruritus—Gemcitabine—lung cancer	8.46e-05	0.000439	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	8.45e-05	0.00175	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	8.44e-05	0.00174	CbGpPWpGaD
Methylprednisolone—Infection—Docetaxel—lung cancer	8.43e-05	0.000437	CcSEcCtD
Methylprednisolone—Feeling abnormal—Etoposide—lung cancer	8.41e-05	0.000436	CcSEcCtD
Methylprednisolone—Diarrhoea—Irinotecan—lung cancer	8.4e-05	0.000436	CcSEcCtD
Methylprednisolone—Prednisolone—ABCB1—lung cancer	8.38e-05	0.0304	CrCbGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	8.36e-05	0.00173	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Etoposide—lung cancer	8.35e-05	0.000433	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—lung cancer	8.35e-05	0.000433	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—lung cancer	8.32e-05	0.000432	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—lung cancer	8.3e-05	0.000431	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—lung cancer	8.3e-05	0.000431	CcSEcCtD
Methylprednisolone—Visual impairment—Methotrexate—lung cancer	8.3e-05	0.00043	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2A7—lung cancer	8.29e-05	0.00171	CbGpPWpGaD
Methylprednisolone—Tachycardia—Docetaxel—lung cancer	8.28e-05	0.000429	CcSEcCtD
Methylprednisolone—Feeling abnormal—Paclitaxel—lung cancer	8.25e-05	0.000428	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—lung cancer	8.24e-05	0.000427	CcSEcCtD
Methylprednisolone—Hypersensitivity—Cisplatin—lung cancer	8.21e-05	0.000426	CcSEcCtD
Methylprednisolone—Betamethasone—ABCB1—lung cancer	8.21e-05	0.0298	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	8.2e-05	0.00169	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Paclitaxel—lung cancer	8.19e-05	0.000425	CcSEcCtD
Methylprednisolone—Diarrhoea—Gemcitabine—lung cancer	8.18e-05	0.000424	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	8.18e-05	0.00169	CbGpPWpGaD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—lung cancer	8.14e-05	0.000422	CcSEcCtD
Methylprednisolone—Dizziness—Irinotecan—lung cancer	8.12e-05	0.000421	CcSEcCtD
Methylprednisolone—Urticaria—Etoposide—lung cancer	8.11e-05	0.000421	CcSEcCtD
Methylprednisolone—Abdominal pain—Etoposide—lung cancer	8.07e-05	0.000419	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—RB1—lung cancer	8.05e-05	0.00166	CbGpPWpGaD
Methylprednisolone—Eye disorder—Methotrexate—lung cancer	8.04e-05	0.000417	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	8.03e-05	0.00166	CbGpPWpGaD
Methylprednisolone—Asthenia—Cisplatin—lung cancer	8e-05	0.000415	CcSEcCtD
Methylprednisolone—Cardiac disorder—Methotrexate—lung cancer	7.99e-05	0.000414	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—lung cancer	7.96e-05	0.000413	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	7.95e-05	0.00164	CbGpPWpGaD
Methylprednisolone—Urticaria—Paclitaxel—lung cancer	7.95e-05	0.000412	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—RARB—lung cancer	7.93e-05	0.00164	CbGpPWpGaD
Methylprednisolone—Hypotension—Docetaxel—lung cancer	7.93e-05	0.000411	CcSEcCtD
Methylprednisolone—Abdominal pain—Paclitaxel—lung cancer	7.91e-05	0.00041	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	7.91e-05	0.00163	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MYC—lung cancer	7.86e-05	0.00162	CbGpPWpGaD
Methylprednisolone—Angiopathy—Methotrexate—lung cancer	7.81e-05	0.000405	CcSEcCtD
Methylprednisolone—Vomiting—Irinotecan—lung cancer	7.8e-05	0.000405	CcSEcCtD
Methylprednisolone—Immune system disorder—Methotrexate—lung cancer	7.77e-05	0.000403	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Methotrexate—lung cancer	7.76e-05	0.000402	CcSEcCtD
Methylprednisolone—Rash—Irinotecan—lung cancer	7.74e-05	0.000401	CcSEcCtD
Methylprednisolone—Dermatitis—Irinotecan—lung cancer	7.73e-05	0.000401	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	7.73e-05	0.0016	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—lung cancer	7.73e-05	0.000401	CcSEcCtD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	7.71e-05	0.00159	CbGpPWpGaD
Methylprednisolone—Headache—Irinotecan—lung cancer	7.69e-05	0.000399	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—lung cancer	7.67e-05	0.000398	CcSEcCtD
Methylprednisolone—Diarrhoea—Cisplatin—lung cancer	7.62e-05	0.000395	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	7.62e-05	0.00157	CbGpPWpGaD
Methylprednisolone—Paraesthesia—Docetaxel—lung cancer	7.62e-05	0.000395	CcSEcCtD
Methylprednisolone—Vomiting—Gemcitabine—lung cancer	7.6e-05	0.000394	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—lung cancer	7.59e-05	0.000394	CcSEcCtD
Methylprednisolone—Mental disorder—Methotrexate—lung cancer	7.54e-05	0.000391	CcSEcCtD
Methylprednisolone—Rash—Gemcitabine—lung cancer	7.54e-05	0.000391	CcSEcCtD
Methylprednisolone—Dermatitis—Gemcitabine—lung cancer	7.53e-05	0.000391	CcSEcCtD
Methylprednisolone—Hypersensitivity—Etoposide—lung cancer	7.52e-05	0.00039	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	7.5e-05	0.00155	CbGpPWpGaD
Methylprednisolone—Malnutrition—Methotrexate—lung cancer	7.49e-05	0.000389	CcSEcCtD
Methylprednisolone—Erythema—Methotrexate—lung cancer	7.49e-05	0.000389	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—lung cancer	7.49e-05	0.000389	CcSEcCtD
Methylprednisolone—Headache—Gemcitabine—lung cancer	7.49e-05	0.000388	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—lung cancer	7.47e-05	0.000388	CcSEcCtD
Methylprednisolone—Dyspepsia—Docetaxel—lung cancer	7.47e-05	0.000387	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	7.46e-05	0.00154	CbGpPWpGaD
Methylprednisolone—Haemorrhage—Doxorubicin—lung cancer	7.45e-05	0.000387	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA3—lung cancer	7.39e-05	0.00153	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Paclitaxel—lung cancer	7.38e-05	0.000383	CcSEcCtD
Methylprednisolone—Asthenia—Etoposide—lung cancer	7.33e-05	0.00038	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—lung cancer	7.32e-05	0.00038	CcSEcCtD
Methylprednisolone—Fatigue—Docetaxel—lung cancer	7.32e-05	0.000379	CcSEcCtD
Methylprednisolone—Nausea—Irinotecan—lung cancer	7.29e-05	0.000378	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	7.29e-05	0.00151	CbGpPWpGaD
Methylprednisolone—Pruritus—Etoposide—lung cancer	7.22e-05	0.000375	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—lung cancer	7.18e-05	0.000373	CcSEcCtD
Methylprednisolone—Asthenia—Paclitaxel—lung cancer	7.18e-05	0.000373	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	7.13e-05	0.00147	CbGpPWpGaD
Methylprednisolone—Nausea—Gemcitabine—lung cancer	7.1e-05	0.000368	CcSEcCtD
Methylprednisolone—Vomiting—Cisplatin—lung cancer	7.09e-05	0.000367	CcSEcCtD
Methylprednisolone—Pruritus—Paclitaxel—lung cancer	7.08e-05	0.000367	CcSEcCtD
Methylprednisolone—Rash—Cisplatin—lung cancer	7.03e-05	0.000364	CcSEcCtD
Methylprednisolone—Dermatitis—Cisplatin—lung cancer	7.02e-05	0.000364	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	7e-05	0.00145	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Docetaxel—lung cancer	6.99e-05	0.000363	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	6.99e-05	0.00144	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Etoposide—lung cancer	6.99e-05	0.000362	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	6.98e-05	0.00144	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—KHSRP—lung cancer	6.97e-05	0.00144	CbGpPWpGaD
Methylprednisolone—Eye disorder—Doxorubicin—lung cancer	6.97e-05	0.000361	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Methotrexate—lung cancer	6.95e-05	0.000361	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—lung cancer	6.94e-05	0.00036	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—lung cancer	6.92e-05	0.000359	CcSEcCtD
Methylprednisolone—Diarrhoea—Paclitaxel—lung cancer	6.85e-05	0.000355	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	6.83e-05	0.00141	CbGpPWpGaD
Methylprednisolone—Angiopathy—Doxorubicin—lung cancer	6.76e-05	0.000351	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA4—lung cancer	6.76e-05	0.0014	CbGpPWpGaD
Methylprednisolone—Malaise—Methotrexate—lung cancer	6.76e-05	0.00035	CcSEcCtD
Methylprednisolone—Dizziness—Etoposide—lung cancer	6.75e-05	0.00035	CcSEcCtD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	6.74e-05	0.00139	CbGpPWpGaD
Methylprednisolone—Immune system disorder—Doxorubicin—lung cancer	6.73e-05	0.000349	CcSEcCtD
Methylprednisolone—Vertigo—Methotrexate—lung cancer	6.73e-05	0.000349	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—lung cancer	6.72e-05	0.000348	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—lung cancer	6.71e-05	0.000348	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	6.68e-05	0.00138	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	6.67e-05	0.00138	CbGpPWpGaD
Methylprednisolone—Arrhythmia—Doxorubicin—lung cancer	6.66e-05	0.000345	CcSEcCtD
Methylprednisolone—Dizziness—Paclitaxel—lung cancer	6.62e-05	0.000343	CcSEcCtD
Methylprednisolone—Nausea—Cisplatin—lung cancer	6.62e-05	0.000343	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA2—lung cancer	6.59e-05	0.00136	CbGpPWpGaD
Methylprednisolone—Mental disorder—Doxorubicin—lung cancer	6.53e-05	0.000339	CcSEcCtD
Methylprednisolone—Convulsion—Methotrexate—lung cancer	6.49e-05	0.000337	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CASP8—lung cancer	6.49e-05	0.00134	CbGpPWpGaD
Methylprednisolone—Vomiting—Etoposide—lung cancer	6.49e-05	0.000337	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—lung cancer	6.49e-05	0.000337	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—lung cancer	6.49e-05	0.000337	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TP53—lung cancer	6.46e-05	0.00133	CbGpPWpGaD
Methylprednisolone—Rash—Etoposide—lung cancer	6.44e-05	0.000334	CcSEcCtD
Methylprednisolone—Dermatitis—Etoposide—lung cancer	6.43e-05	0.000334	CcSEcCtD
Methylprednisolone—Hydrocortisone—ABCB1—lung cancer	6.41e-05	0.0232	CrCbGaD
Methylprednisolone—Headache—Etoposide—lung cancer	6.4e-05	0.000332	CcSEcCtD
Methylprednisolone—Myalgia—Methotrexate—lung cancer	6.38e-05	0.000331	CcSEcCtD
Methylprednisolone—Arthralgia—Methotrexate—lung cancer	6.38e-05	0.000331	CcSEcCtD
Methylprednisolone—Vomiting—Paclitaxel—lung cancer	6.36e-05	0.00033	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—GSTA1—lung cancer	6.36e-05	0.00131	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	6.34e-05	0.00131	CbGpPWpGaD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.34e-05	0.000329	CcSEcCtD
Methylprednisolone—Rash—Paclitaxel—lung cancer	6.31e-05	0.000327	CcSEcCtD
Methylprednisolone—Dermatitis—Paclitaxel—lung cancer	6.31e-05	0.000327	CcSEcCtD
Methylprednisolone—Discomfort—Methotrexate—lung cancer	6.3e-05	0.000327	CcSEcCtD
Methylprednisolone—Headache—Paclitaxel—lung cancer	6.27e-05	0.000325	CcSEcCtD
Methylprednisolone—Hypersensitivity—Docetaxel—lung cancer	6.25e-05	0.000324	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	6.22e-05	0.00128	CbGpPWpGaD
Methylprednisolone—Confusional state—Methotrexate—lung cancer	6.17e-05	0.00032	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Methotrexate—lung cancer	6.12e-05	0.000317	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—EIF2B5—lung cancer	6.09e-05	0.00126	CbGpPWpGaD
Methylprednisolone—Asthenia—Docetaxel—lung cancer	6.09e-05	0.000316	CcSEcCtD
Methylprednisolone—Infection—Methotrexate—lung cancer	6.08e-05	0.000315	CcSEcCtD
Methylprednisolone—Nausea—Etoposide—lung cancer	6.06e-05	0.000315	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—lung cancer	6.02e-05	0.000312	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—lung cancer	6e-05	0.000311	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	6e-05	0.00124	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	6e-05	0.00124	CbGpPWpGaD
Methylprednisolone—Nervous system disorder—Methotrexate—lung cancer	6e-05	0.000311	CcSEcCtD
Methylprednisolone—Nausea—Paclitaxel—lung cancer	5.95e-05	0.000308	CcSEcCtD
Methylprednisolone—Skin disorder—Methotrexate—lung cancer	5.94e-05	0.000308	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—lung cancer	5.91e-05	0.00122	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Methotrexate—lung cancer	5.91e-05	0.000307	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—UGT1A1—lung cancer	5.91e-05	0.00122	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	5.86e-05	0.00121	CbGpPWpGaD
Methylprednisolone—Malaise—Doxorubicin—lung cancer	5.85e-05	0.000303	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—lung cancer	5.83e-05	0.000302	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	5.83e-05	0.0012	CbGpPWpGaD
Methylprednisolone—Syncope—Doxorubicin—lung cancer	5.82e-05	0.000302	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—lung cancer	5.81e-05	0.000301	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—CDKN1A—lung cancer	5.78e-05	0.00119	CbGpPWpGaD
Methylprednisolone—Hypotension—Methotrexate—lung cancer	5.71e-05	0.000296	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—lung cancer	5.7e-05	0.000296	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	5.69e-05	0.00118	CbGpPWpGaD
Methylprednisolone—Convulsion—Doxorubicin—lung cancer	5.62e-05	0.000292	CcSEcCtD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	5.62e-05	0.00116	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—lung cancer	5.61e-05	0.0204	CrCbGaD
Methylprednisolone—Dizziness—Docetaxel—lung cancer	5.61e-05	0.000291	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—lung cancer	5.6e-05	0.000291	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Methotrexate—lung cancer	5.57e-05	0.000289	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	5.55e-05	0.00115	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	5.54e-05	0.00114	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	5.54e-05	0.00114	CbGpPWpGaD
Methylprednisolone—Insomnia—Methotrexate—lung cancer	5.53e-05	0.000287	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—lung cancer	5.52e-05	0.000286	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—lung cancer	5.52e-05	0.000286	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	5.51e-05	0.00114	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—DICER1—lung cancer	5.51e-05	0.00114	CbGpPWpGaD
Methylprednisolone—Anxiety—Doxorubicin—lung cancer	5.5e-05	0.000286	CcSEcCtD
Methylprednisolone—Paraesthesia—Methotrexate—lung cancer	5.49e-05	0.000285	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.49e-05	0.000285	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—lung cancer	5.46e-05	0.000283	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	5.45e-05	0.00113	CbGpPWpGaD
Methylprednisolone—Vomiting—Docetaxel—lung cancer	5.39e-05	0.00028	CcSEcCtD
Methylprednisolone—Dyspepsia—Methotrexate—lung cancer	5.38e-05	0.000279	CcSEcCtD
Methylprednisolone—Rash—Docetaxel—lung cancer	5.35e-05	0.000277	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—lung cancer	5.34e-05	0.000277	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—lung cancer	5.34e-05	0.000277	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—lung cancer	5.32e-05	0.000276	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	5.31e-05	0.0011	CbGpPWpGaD
Methylprednisolone—Anaphylactic shock—Doxorubicin—lung cancer	5.3e-05	0.000275	CcSEcCtD
Methylprednisolone—Fatigue—Methotrexate—lung cancer	5.27e-05	0.000273	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—lung cancer	5.26e-05	0.000273	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	5.21e-05	0.00108	CbGpPWpGaD
Methylprednisolone—Shock—Doxorubicin—lung cancer	5.21e-05	0.00027	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	5.21e-05	0.00108	CbGpPWpGaD
Methylprednisolone—Nervous system disorder—Doxorubicin—lung cancer	5.19e-05	0.000269	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—lung cancer	5.17e-05	0.000268	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—STAT3—lung cancer	5.16e-05	0.00107	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	5.15e-05	0.00106	CbGpPWpGaD
Methylprednisolone—Skin disorder—Doxorubicin—lung cancer	5.14e-05	0.000267	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL8—lung cancer	5.13e-05	0.00106	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Doxorubicin—lung cancer	5.12e-05	0.000266	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	5.09e-05	0.00105	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	5.08e-05	0.00105	CbGpPWpGaD
Methylprednisolone—Nausea—Docetaxel—lung cancer	5.04e-05	0.000261	CcSEcCtD
Methylprednisolone—Feeling abnormal—Methotrexate—lung cancer	5.04e-05	0.000261	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—HPGDS—lung cancer	5.02e-05	0.00104	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Methotrexate—lung cancer	5e-05	0.000259	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—lung cancer	4.95e-05	0.000257	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CASP3—lung cancer	4.91e-05	0.00101	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL2—lung cancer	4.91e-05	0.00101	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTT1—lung cancer	4.87e-05	0.00101	CbGpPWpGaD
Methylprednisolone—Urticaria—Methotrexate—lung cancer	4.86e-05	0.000252	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	4.85e-05	0.001	CbGpPWpGaD
Methylprednisolone—Abdominal pain—Methotrexate—lung cancer	4.83e-05	0.000251	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.82e-05	0.00025	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2A6—lung cancer	4.82e-05	0.000995	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GCLC—lung cancer	4.82e-05	0.000995	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	4.81e-05	0.000994	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	4.81e-05	0.000992	CbGpPWpGaD
Methylprednisolone—Insomnia—Doxorubicin—lung cancer	4.79e-05	0.000248	CcSEcCtD
Methylprednisolone—Dexamethasone—ABCB1—lung cancer	4.77e-05	0.0173	CrCbGaD
Methylprednisolone—NR3C1—Gene Expression—SKI—lung cancer	4.76e-05	0.000982	CbGpPWpGaD
Methylprednisolone—Paraesthesia—Doxorubicin—lung cancer	4.75e-05	0.000247	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	4.75e-05	0.000982	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	4.69e-05	0.000968	CbGpPWpGaD
Methylprednisolone—Dyspepsia—Doxorubicin—lung cancer	4.66e-05	0.000242	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—lung cancer	4.57e-05	0.000237	CcSEcCtD
Methylprednisolone—Hypersensitivity—Methotrexate—lung cancer	4.51e-05	0.000234	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	4.5e-05	0.00093	CbGpPWpGaD
Methylprednisolone—Asthenia—Methotrexate—lung cancer	4.39e-05	0.000228	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—lung cancer	4.36e-05	0.000226	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—lung cancer	4.33e-05	0.000225	CcSEcCtD
Methylprednisolone—Pruritus—Methotrexate—lung cancer	4.33e-05	0.000224	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	4.31e-05	0.000889	CbGpPWpGaD
Methylprednisolone—Urticaria—Doxorubicin—lung cancer	4.21e-05	0.000218	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—AZIN2—lung cancer	4.2e-05	0.000868	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—COL4A3BP—lung cancer	4.2e-05	0.000868	CbGpPWpGaD
Methylprednisolone—Abdominal pain—Doxorubicin—lung cancer	4.19e-05	0.000217	CcSEcCtD
Methylprednisolone—Diarrhoea—Methotrexate—lung cancer	4.18e-05	0.000217	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—lung cancer	4.17e-05	0.000861	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	4.13e-05	0.000853	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2E1—lung cancer	4.1e-05	0.000846	CbGpPWpGaD
Methylprednisolone—Dizziness—Methotrexate—lung cancer	4.04e-05	0.00021	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	4.04e-05	0.000834	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.96e-05	0.000819	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Doxorubicin—lung cancer	3.9e-05	0.000202	CcSEcCtD
Methylprednisolone—Vomiting—Methotrexate—lung cancer	3.89e-05	0.000202	CcSEcCtD
Methylprednisolone—Rash—Methotrexate—lung cancer	3.86e-05	0.0002	CcSEcCtD
Methylprednisolone—Dermatitis—Methotrexate—lung cancer	3.85e-05	0.0002	CcSEcCtD
Methylprednisolone—Headache—Methotrexate—lung cancer	3.83e-05	0.000199	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—RARB—lung cancer	3.82e-05	0.000789	CbGpPWpGaD
Methylprednisolone—Asthenia—Doxorubicin—lung cancer	3.8e-05	0.000197	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—lung cancer	3.75e-05	0.000194	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	3.72e-05	0.000769	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NPPA—lung cancer	3.72e-05	0.000769	CbGpPWpGaD
Methylprednisolone—Nausea—Methotrexate—lung cancer	3.63e-05	0.000188	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—lung cancer	3.62e-05	0.000188	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—IL6—lung cancer	3.6e-05	0.000744	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ATP5H—lung cancer	3.57e-05	0.000738	CbGpPWpGaD
Methylprednisolone—Dizziness—Doxorubicin—lung cancer	3.5e-05	0.000182	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.44e-05	0.00071	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.4e-05	0.000702	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.38e-05	0.000698	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	3.38e-05	0.000697	CbGpPWpGaD
Methylprednisolone—Vomiting—Doxorubicin—lung cancer	3.37e-05	0.000175	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—lung cancer	3.34e-05	0.000173	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—lung cancer	3.34e-05	0.000173	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.33e-05	0.000688	CbGpPWpGaD
Methylprednisolone—Headache—Doxorubicin—lung cancer	3.32e-05	0.000172	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	3.2e-05	0.000662	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HSPB1—lung cancer	3.2e-05	0.000661	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	3.19e-05	0.000659	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLBD1—lung cancer	3.18e-05	0.000657	CbGpPWpGaD
Methylprednisolone—Nausea—Doxorubicin—lung cancer	3.15e-05	0.000163	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	3.11e-05	0.000643	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—lung cancer	3.1e-05	0.000641	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	3.07e-05	0.000634	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	3.06e-05	0.000632	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	3.04e-05	0.000629	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	3.04e-05	0.000627	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	3.04e-05	0.000627	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	2.95e-05	0.000609	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.94e-05	0.000608	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD17B10—lung cancer	2.91e-05	0.000601	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.9e-05	0.000599	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.82e-05	0.000583	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NOTCH3—lung cancer	2.82e-05	0.000583	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.71e-05	0.000559	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CKB—lung cancer	2.71e-05	0.000559	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.7e-05	0.000558	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—JUNB—lung cancer	2.67e-05	0.000552	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.67e-05	0.000552	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.61e-05	0.000539	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.59e-05	0.000534	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AZIN2—lung cancer	2.59e-05	0.000534	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CNDP2—lung cancer	2.55e-05	0.000526	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM2—lung cancer	2.55e-05	0.000526	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTMR3—lung cancer	2.48e-05	0.000511	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.42e-05	0.000501	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PGAM1—lung cancer	2.41e-05	0.000498	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.36e-05	0.000487	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.35e-05	0.000486	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2A7—lung cancer	2.3e-05	0.000475	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.28e-05	0.000471	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.28e-05	0.00047	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SDC4—lung cancer	2.25e-05	0.000465	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ATP5H—lung cancer	2.2e-05	0.000454	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—POMC—lung cancer	2.19e-05	0.000453	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.17e-05	0.000449	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.11e-05	0.000436	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.06e-05	0.000425	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—RRM1—lung cancer	2.05e-05	0.000424	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA3—lung cancer	2.05e-05	0.000424	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLBD1—lung cancer	1.96e-05	0.000405	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.96e-05	0.000404	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.95e-05	0.000402	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ERCC2—lung cancer	1.94e-05	0.0004	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—B4GALT5—lung cancer	1.93e-05	0.000398	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.89e-05	0.000391	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA4—lung cancer	1.88e-05	0.000387	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.85e-05	0.000382	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA2—lung cancer	1.83e-05	0.000378	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD17B10—lung cancer	1.79e-05	0.00037	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA1—lung cancer	1.76e-05	0.000364	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	1.75e-05	0.000361	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.75e-05	0.000361	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCC3—lung cancer	1.74e-05	0.00036	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKR1C1—lung cancer	1.69e-05	0.000349	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CKB—lung cancer	1.67e-05	0.000344	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UGT1A1—lung cancer	1.64e-05	0.000339	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.61e-05	0.000332	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GNG11—lung cancer	1.58e-05	0.000327	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM2—lung cancer	1.57e-05	0.000324	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CNDP2—lung cancer	1.57e-05	0.000324	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.55e-05	0.000321	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTMR3—lung cancer	1.53e-05	0.000315	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDOA—lung cancer	1.51e-05	0.000311	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.5e-05	0.000309	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PGAM1—lung cancer	1.49e-05	0.000307	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA3—lung cancer	1.46e-05	0.000302	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ADCY1—lung cancer	1.42e-05	0.000294	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG2—lung cancer	1.42e-05	0.000294	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CREBBP—lung cancer	1.42e-05	0.000293	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2A7—lung cancer	1.42e-05	0.000293	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HPGDS—lung cancer	1.39e-05	0.000288	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ENO2—lung cancer	1.39e-05	0.000288	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SDC4—lung cancer	1.39e-05	0.000287	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPP2R1B—lung cancer	1.39e-05	0.000286	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTT1—lung cancer	1.35e-05	0.000279	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2A6—lung cancer	1.34e-05	0.000276	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GCLC—lung cancer	1.34e-05	0.000276	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.31e-05	0.000271	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ENO1—lung cancer	1.27e-05	0.000262	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.27e-05	0.000262	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA3—lung cancer	1.26e-05	0.000261	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—RRM1—lung cancer	1.26e-05	0.000261	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—B4GALT5—lung cancer	1.19e-05	0.000245	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.19e-05	0.000245	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA4—lung cancer	1.16e-05	0.000239	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2E1—lung cancer	1.14e-05	0.000235	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA2—lung cancer	1.13e-05	0.000233	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NQO1—lung cancer	1.12e-05	0.000232	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA1—lung cancer	1.09e-05	0.000224	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCC3—lung cancer	1.07e-05	0.000222	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.07e-05	0.000221	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKR1C1—lung cancer	1.04e-05	0.000215	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—STK11—lung cancer	1.01e-05	0.000209	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UGT1A1—lung cancer	1.01e-05	0.000209	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GNG11—lung cancer	9.74e-06	0.000201	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTP1—lung cancer	9.38e-06	0.000194	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDOA—lung cancer	9.28e-06	0.000192	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAT—lung cancer	9.12e-06	0.000188	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA3—lung cancer	9.01e-06	0.000186	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG2—lung cancer	8.76e-06	0.000181	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADCY1—lung cancer	8.76e-06	0.000181	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TYMS—lung cancer	8.72e-06	0.00018	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MAPK3—lung cancer	8.66e-06	0.000179	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—lung cancer	8.62e-06	0.000178	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ENO2—lung cancer	8.59e-06	0.000177	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HPGDS—lung cancer	8.59e-06	0.000177	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.54e-06	0.000176	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—lung cancer	8.43e-06	0.000174	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTT1—lung cancer	8.33e-06	0.000172	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2A6—lung cancer	8.24e-06	0.00017	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GCLC—lung cancer	8.24e-06	0.00017	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A1—lung cancer	8.17e-06	0.000169	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ERCC2—lung cancer	8.1e-06	0.000167	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ENO1—lung cancer	7.81e-06	0.000161	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOA1—lung cancer	7.01e-06	0.000145	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2E1—lung cancer	7e-06	0.000145	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NQO1—lung cancer	6.93e-06	0.000143	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CG—lung cancer	6.4e-06	0.000132	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—STK11—lung cancer	6.24e-06	0.000129	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—POMC—lung cancer	6.09e-06	0.000126	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CREBBP—lung cancer	5.93e-06	0.000122	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—lung cancer	5.84e-06	0.000121	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTP1—lung cancer	5.78e-06	0.000119	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CD—lung cancer	5.62e-06	0.000116	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAT—lung cancer	5.62e-06	0.000116	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—lung cancer	5.55e-06	0.000115	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCB1—lung cancer	5.47e-06	0.000113	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TYMS—lung cancer	5.37e-06	0.000111	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—lung cancer	5.31e-06	0.00011	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A1—lung cancer	5.03e-06	0.000104	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ERCC2—lung cancer	4.99e-06	0.000103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CB—lung cancer	4.9e-06	0.000101	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—lung cancer	4.86e-06	0.0001	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOA1—lung cancer	4.32e-06	8.92e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTEN—lung cancer	4.24e-06	8.75e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—EP300—lung cancer	4.04e-06	8.34e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CG—lung cancer	3.94e-06	8.14e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—POMC—lung cancer	3.75e-06	7.75e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CREBBP—lung cancer	3.65e-06	7.55e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CD—lung cancer	3.46e-06	7.16e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—lung cancer	3.42e-06	7.06e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CB—lung cancer	3.02e-06	6.24e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—lung cancer	2.99e-06	6.18e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CA—lung cancer	2.99e-06	6.17e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTEN—lung cancer	2.61e-06	5.39e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—EP300—lung cancer	2.49e-06	5.14e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—lung cancer	2.44e-06	5.04e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.84e-06	3.8e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—lung cancer	1.5e-06	3.11e-05	CbGpPWpGaD
